Palvella Therapeutics to participate in upcoming healthcare investor conferences
Palvella Therapeutics, Inc. said it will participate in upcoming healthcare investor conferences, according to a Globe Newswire announcement.
WAYNE, Pa., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) NASDAQ:PVLA, a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for serious, rare skin diseases and vascular malformations for which there are no…